Hybrid approach in patients with aortic valve disease and concomitant coronary heart disease: retrospective study.

Abstract

Objective: Aim: The aim of the study was to analyze the effectiveness of the hybrid approach, which involves the combination of aortic valve replacement (AVR) with percutaneous coronary intervention (PCI), in patients with CHD and aortic valve disease..

Patients and methods: Materials and Methods: For this study, analysis of medical records of adult patients (over 18 years old) who underwent AVR along with myocardial revascularization at the State Institution "Heart Institute Ministry of Health of Ukraine" in the period from 2018 to 2022 was carried out. Quality of life was assessed in 6 and 12 months after AVR with myocardial revascularization using Short Form 36 Survey (SF-36).

Results: Results: We selected 130 patients who underwent AVR together with myocardial revascularization (first group (n=51) - a combination of AVR and percutaneous coronary interventions (PCI); second group (n=79) - a combination of AVR and coronary artery bypass grafting (CABG). The duration of cardiopulmonary bypass and aorta cross clamping in first group was recorded by 1.5 times and by 1.4 times significantly lower compared to the second group (p=0.0001). The pain index after 6 months according to the SF-36 questionnaire was found to be 13.5% (p=0.017) significantly higher in patients of the first group compared to the second group, while other indicators did not differ among groups.

Conclusion: Conclusions: Patients with the hybrid approach of treatment were characterized by a similar level of postoperative complications with the surgical group. At the same time, this cohort of patients had a better SF-36 pain index in 6 months after the hybrid intervention.